In 2024, we continued to establish Johnson & Johnson as healthcare’s leading, most comprehensive innovation powerhouse. With our focus on pharmaceuticals and medical technology, we stand alone …

Investors also should carefully read the risk factors described in Item 1A of this Annual Report on Form 10-K for a description of certain risks that could, among other things, cause the Company’s actual …

We performed in line or ahead of our competitive composite for the past two years. Growth was driven by our focused commercial strategies, the successful launch of diferentiated products, and …

Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy. The print and digital publications we produce each year that recap the company’s …

Click on each topic below to find more information, including the company’s relevant policy or position, related content on Johnson & Johnson websites and relevant disclosures in our annual Health for …

Jan 3, 2021 · Investors also should carefully read the Risk Factors described in Item 1A of this Annual Report on Form 10-K for a description of certain risks that could, among other things, cause the …

Johnson & Johnson does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Johnson & Johnson and its subsidiaries (the Company) have approximately 152,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of …

Feb 16, 2024 · Johnson & Johnson (JNJ) Annual Reports 2002-2025 NYSE:JNJ (526.8B) ... See all annual reports in the United States

Dec 29, 2013 · See also PFIZER INC - Annual report 2022 (10-K 2022-12-31) Annual report 2023 (10-Q 2023-10-01) See also AbbVie Inc. - Annual report 2022 (10-K 2022-12-31) Annual report 2023 (10-Q …